Should I buy Morgan Stanley (MS) stock or is it too late?
⭐ The most reliable of them, either direction: HSBC — 76% of its targets hit on this sector (25 calls tested). It aims for $215 (+0.1 %), call made on July 22, 2026, maturing on July 22, 2027 (37 d ago).
Firm-by-firm track record on Morgan Stanley
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| B of A Securities | 92 % | +50.0 % | 12 | $250 +16% |
| Citigroup | 88 % | +41.7 % | 8 | $235 +9% |
| UBS | 75 % | +31.6 % | 8 | $260 +21% |
| Oppenheimer | 77 % | +28.2 % | 22 | $105 -51% |
| Evercore ISI Group | 80 % | +27.2 % | 10 | $240 +12% |
| JP Morgan | 67 % | +27.1 % | 6 | $195 -9% |
| Barclays | 83 % | +17.8 % | 12 | $262 +22% |
| BMO Capital | 69 % | +13.2 % | 13 | $250 +16% |
✅ Reasons to believe
- Median price target $240, i.e. +12% from the current price ($215).
- The most reliable firm on MS, HSBC (100% hit rate, 3 scored calls), targets $215 (call made on July 21, 2026, maturing on July 21, 2027) (+0%) in its most recent call.
- 6 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
- Pays a dividend (1.9% yield), raised for 12 years — regular income on top of potential upside.
- Reasonable valuation (P/E ~17) relative to its sector.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 15 ratings, 7 are neutral and 1 is a sell.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on MS
Median target $240 (+12%) · 15 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Morgan Stanley now?
We won't decide for you. The facts: 47% of analysts rate it a buy, median target $240 (+12%), and HSBC (most reliable on MS, 100%) targets $215. Weigh that against valuation (P/E ~17). This is not personalized advice.
Is it too late to invest in Morgan Stanley?
Not according to analysts: the median target ($240) is still +12% above the current price ($215) (most reliable on MS: HSBC, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Morgan Stanley still worth investing in?
It depends on the gap between the price ($215) and its estimated value: analysts target $240 on median (+12%), with 47% buys (most reliable on MS: HSBC, 100%). Cross-check with their real reliability on MS and the cautions above. Information, not advice.
What's the main risk in buying MS?
The consensus is not unanimous: of 15 ratings, 7 are neutral and 1 is a sell.
→ Go deeper: the full Morgan Stanley profile (consensus, analyst reliability, price target, performance).